Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospitals of North Midlands NHS Trust
This is a pilot study taking place at University Hospitals of North Midlands NHS Trust. Patients referred for MRI for possible prostate cancer will be invited to take part in the study. Following consent, participants will have an additional MRI sequence performed during their routine MRI called Double Inversion Magnetic Resonance Imaging (DIR-MRI). Participants scan images and prostate biopsy histology report (if applicable) will be reviewed by the research team. The research team will look at the variability of LNR score amongst the two scan typed and the DCE-MRI and DIR-MRI images will be correlated with biopsy results to give an indication of the accuracy.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients referred for prostate MRI for possible prostate cancer
Safe to undergo an MRI scan
Able to give informed consent
You may not be if
MRI referrals where prostate cancer is not the question
Patients who are not safe to undergo an MRI scan
Patients who have undergone prostate biopsy in the previous 10 weeks
Patients unable to give informed consent
Clareo Health | Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study
